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Background: Percutaneous coronary intervention (PCI) in patients with acute coronary
syndrome (ACS) should be performed in presence of objective evidence of myocardial
ischemia. Our study investigated the appropriateness of PCI among ACS patients in Russia
and explored clinical factors associated with PCI performance.
Methods and results: Clinical information about 65,912 ACS patients (60.5% male, aged
63.2713.8 years) enrolled in the 2010–2011 Russian ACS Registry was examined. ACCF 2012
criteria were used to assess the appropriateness of PCI. PCI was performed in 13.8% of
patients included in the study. Among patients with performed PCI (ACS-PCI patients),
it was appropriate in 68.9%. In patients refused from PCI (ACS-nonPCI patients), it would be
appropriate in 57.9% patients. Main clinical factors related to PCI were age, male sex, prior
PCI, ST-segment elevation on ECG, and accordance with any of ACCF 2012 appropriate use
criteria. But these factors were attributable for ACS-PCI patients only. It was a low
correlation between these clinical factors and refuse from PCI.
Conclusions: It was shown that intervention was appropriate in the most patients with ACS
received PCI. Among patients, refused from revascularization, PCI would be appropriate in
more than half of them. We revealed that several clinical characteristics of ACS patients,
including ACCF 2012 criteria, are fundamental for the decision to conduct PCI, but the
negative decision was determined by other, non-clinical factors.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.Introduction
Percutaneous coronary interventions (PCI) today are available for
themost of patients with acute coronary syndromes (ACS) due toch Society of Cardiology.
titute of Cardiology, 141,
Kiselev).modern medical technologies. Guidelines for PCI implementa-
tion were developed to facilitate clinical decision making [1,2].
Recent guidelines on coronary revascularization promote early
coronary angiography in anticipation of revascularization [3–6].Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0e2In ACS patients, PCI should be performed with the appropriate
clinical and objective evidence of myocardial ischemia [1,7].
Clear criteria for PCI implementation in ACS patients were
deﬁned by ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT in
2009 and had been updated in 2012 (hereafter referred as ACCF
2012) [8,9]. European criteria for PCI performance were developed
previously [10]. These criteria cover the most clinical conditions
occurring in ACS patients. The use of appropriateness criteria
(ACCF 2012 especially) allows one to avoid inappropriate inter-
ventions in ACS patients. PCI appropriate use criteria potentially
may be used in routine clinical practice, ﬁrstly for selecting
patients who may beneﬁt from intervention and, secondly, for
evaluating the appropriateness of performed procedures. While
several deﬁciencies are observed in PCI appropriateness criteria,
their use is already clinically and economically justiﬁed now
[11–13].
The aims of the present study were(i) to analyze the appropriateness of performed PCI with the
help of ACCF 2012 criteria;(ii) to evaluate the potential need in PCI among ACS patients
refused from the intervention, with the help of ACCF
2012 criteria;(iii) to explore the impact of clinical factors, inﬂuencing on
PCI performance/refuse in ACS patients.Material and methods
Data source
The Registry of Acute Coronary Syndrome of the Ministry of
Health of Russian Federation (hereafter referred as Russian ACS
Registry) was used as a source of data about ACS patients [14].
It is retrospective, continuous, nation-wide, Web-based registry
working on-line.
Participation in the Russian ACS Registry is voluntary. The
access to the registry is given to registered members. Centers
participating in the Registry asked to include all patients
following inclusion/exclusion criteria treated from ACS during
the year prior to the year of participation. The source of
patient’s data is a hospital chart.
Russian ACS Registry inclusion criteria [15]:(i) age Z18 years;
(ii) any type of ACS as a presumptive diagnosis;
(iii) patient's hospital chart is ﬁnished;
(iv) absence of any exclusion criteria.Russian ACS Registry exclusion criteria [15]:(i) symptoms considered as consistent with acute cardiac
ischemia are absent within the last 24 h prior to admission;(ii) patient was transferred into a registry hospital 424 h
after admission to the initial hospital;(iii) patient was transferred out of a registry hospital o24 h
after admission;(iv) patients who develop ACS symptoms while hospitalized
for any reason;(v) ACS accompanied by a signiﬁcant co-morbidity such as a
motor vehicle accident, trauma, severe gastrointestinal
bleeding, operation or procedure directly before admission.Registry database is developed using ACCF/AHA 2011 Key
Data Elements and Deﬁnitions of a Base Cardiovascular
Vocabulary for Electronic Health Records [16]. Data on clinical
characteristics, prior and hospital drug treatment, and reper-
fusion therapy are collected. Data on post-hospital treatment
of ACS patients is not included in the registry database.
Patient selection
The following enrollment criteria were used for the purposes
of the present study:(i) age between 18 and 80 years.
(ii) acute myocardial infarction or unstable angina as a
diagnosis at discharge.
The patients over 80 years were not included in the present
study because of proven disparities in treatment of ACS between
the older and the younger people [17–19]. It was previously
reported that the high age itself is a predominant clinical factor
inﬂuencing on implementation of invasive treatment among
aged patients in Russia in spite of their higher risk of inhospital
death [20,21]. This restriction of the present study is indicated in
the Limitation section.
Patients were rejected from the study, if they had one of
the following exclusion criteria:(i) missing of data on the time of reperfusion (time of ﬁbrino-
lytic agent injection and/or time of balloon inﬂation
during PCI),(ii) missing of principal data on the hospital presentation,
treatment and history of the present event,(iii) data entry errors.Study population
Data from 65,912 patients with ACS (aged 63.2713.8 years, 60.5%
male) enrolled in the 2010/2011 Russian ACS Registry following
the study inclusion/exclusion criteria were examined.
Enrolled patients were treated in 155 cardiological ofﬁces
in 46 regions of Russia. 53% of patients were admitted to the
invasive hospitals.
All ACS patients included in the study were divided into
two groups according to the presence or absence of PCI
during hospital stay. The ﬁrst group was composed of
patients (n¼9147, 13.8%) with performed PCI. This group
was named as ACS-PCI patients. The second group was
composed of patients (n¼56,765, 86.2%) refused from PCI.
This group was named as ACS-nonPCI patients. Demographic
and clinical characteristics of patients are shown in Table 1.
ACS-PCI patients differed from ACS-nonPCI patients by the
most of demographic and clinical parameters. ACS-PCI
patients were younger, more frequently to be of male sex.
They smoked more frequently. ACS-PCI patients more rarely
Table 1 – Demographic and clinical characteristics of ACS patients enrolled in the 2010/2011 Russian ACS Registry.
Parameters ACS-PCI patients (n¼9147) ACS-nonPCI patients (n¼56,765) P-level
Male sex, % 77.6 57.7 o0.001
Age, years, M7SD 57.8712.2 64.1713.9 o0.001
Height, cm, Me (Q1, Q3) 170 (160, 176) 165 (150, 172) o0.001
Weight, kg, Me (Q1, Q3) 79 (68, 89) 74 (56, 85) o0.001
BMI, kg/m2, Me (Q1, Q3) 27.5 (25.0, 30.5) 27.5 (24.9, 30.9) 0.942
Prior MI, % 21.2 28.1 o0.001
History of Stable angina pectoris, % 44.3 59.5 o0.001
Family history of CAD, % 38.4 33.0 o0.001
Prior PCI, % 6.5 3.1 o0.001
Prior CABG, % 0.6 2.0 o0.001
History of CHF, % 30.1 46.7 o0.001
Prior stroke (including transient ischemic attack), % 5.2 8.2 o0.001
History of PVD, % 5.0 5.8 0.002
History of CRI, % 1.3 3.3 o0.001
History of COLD, % 6.2 9.2 o0.001
History of AH, % 84.3 88.4 o0.001
Smoking, % 42.6 23.8 o0.001
History of diabetes, % 15.0 18.6 o0.001
Prior drug treatment, %:
Aspirin 34.2 39.2 o0.001
Clopidogrel 10.9 4.8 o0.001
Nitrates 24.2 34.3 o0.001
ACE-Is or ARBs 39.3 49.6 o0.001
β-blockers 33.5 37.8 o0.001
DCA 6.7 8.4 o0.001
NDCA 1.0 2.1 o0.001
Varfarin 0.9 1.3 0.001
Statins 19.8 15.4 o0.001
Clinical status of patients at the admission to hospital
HR, beats/min, M7SD 75.2717.3 78.8719.0 o0.001
SBP, mmHg, M7SD 134.2728.1 139.9729.4 o0.001
DBP, mmHg, M7SD 81.9717.9 83.9716.1 o0.001
AHF, %: o0.001
Killip I 86.1 80.5
Killip II 9.9 13.9
Killip III 1.7 3.4
Killip IV 2.3 2.2
ST-segment elevation on ECG, % 67.4 37.9 o0.001
Pathological Q-wave on ECG, % 28.8 23.4 o0.001
LVEF, %, median (Q1, Q3) 53 (46, 60) 52 (40, 61) o0.001
RV dilatation, % 4.9 9.2 o0.001
LV aneurism, % 5.4 4.3 o0.001
LV thrombus, % 2.9 2.5 0.059
Total cholesterol, mmol/L, Me (Q1, Q3) 4.8 (3.2, 5.8) 4.9 (3.7, 5.9) o0.001
Triglycerides, mmol/L, Me (Q1, Q3) 1.1 (0.3, 1.9) 0.9 (0.4, 1.6) o0.001
Creatinine, micromoles/L, Me (Q1, Q3) 86 (65, 103) 87 (63, 108) o0.001
Blood glucose, mmol/L, Me (Q1, Q3) 5.5 (4.5, 7.0) 5.3 (4.3, 6.6) o0.001
Hemoglobin, g/l, Me (Q1, Q3) 141 (129, 152) 137 (124, 149) o0.001
Hospital treatment
CABG, % 0.4 0.5 0.180
Fibrinolytic therapy, % 13.7 12.9 0.032
Drug treatment, %:
Aspirin 98.7 96.1 o0.001
Clopidogrel 98.1 69.9 o0.001
Nitrates 81.9 86.6 o0.001
Anticoagulants 97.4 93.2 o0.001
ACE inhibitors or ARBs 89.5 83.7 o0.001
β-blockers 93.7 89.1 o0.001
DCA 14.5 14.6 0.759
NDCA 1.6 2.7 o0.001
Varfarin 2.6 2.9 0.053
Statins 84.9 78.2 o0.001
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0 e3
Table 1 (continued )
Parameters ACS-PCI patients (n¼9147) ACS-nonPCI patients (n¼56,765) P-level
Clinical outcomes
In-hospital mortality, % 2.6 5.0 o0.001
BMI, body mass index; MI, myocardial infarction; CAD, coronary artery disease; CABG, coronary artery bypass grafting; CHF, chronic heart
failure; PVD, peripheral vascular disease; CRI; chronic renal insufﬁciency; COLD, chronic obstructive lung disease; AH, arterial hypertension;
ACE-Is, angiotensin-converting enzyme inhibitors; ARBs, angiotensin-receptor blockers; DCA, dihydropyridine calcium antagonists; NDCA, no
dihydropyridine calcium antagonists; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; AHF, acute heart failure; ECG,
electrocardiogram; LVEF, left ventricular ejection fraction; RV, right ventricle; LF, left ventricle; Hb, hemoglobin.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0e4had a history of stable angina and congenital heart failure in
comparison to ACS-nonPCI patients. They were more rarely
treated with nitrates and more frequently treated with
clopidogrel prior to admission. At hospital presentation,
ACS-PCI patients almost twice frequently had ST-segment
elevation on electrocardiogram as compared with ACS-
nonPCI patients. Inhospital mortality of ACS-PCI patients
was twice lower than inhospital mortality of ACS-nonPCI
patients (2.6% vs. 5.0%, respectively).ACCF 2012 PCI appropriate use criteria
ACCF 2012 criteria [9] were used to evaluate PCI appropriate-
ness in all ACS-PCI patients. In ACS-nonPCI patients these
criteria were used to assess the potential need for PCI.
ACCF 2012 criteria nos. 1, 2, 4, 6, 10, 11, 12 and 13 (Table 2)
were used to determine ACS patients in whom PCI was
appropriate. Inappropriate PCI was determined with the help
of ACCF 2012 criteria no. 3 (Table 2). Criteria nos. 5 and 9
(Table 2) determined ACS patients in whom the appropriate-
ness of PCI was uncertain. In the present study we do not use
ACCF 2012 criteria nos. 7 and 8, because these criteria
assessed cases of repeated PCI, but Russian Register of ACS
does not contain such data.Statistical analysis
We applied the Chi-square test to compare the binary vari-
ables and to compute the signiﬁcance level for the differences
between the two proportions. Mann–Whitney test was used
to compare the continuous variables. Categorical data were
presented as frequencies and percentages. Continuous vari-
ables were reported as medians (Me) with inter-quartile
ranges (Q1, Q3) for non-normal data or mean (M) with
standard deviation (SD) for normal data.
Backward stepwise discriminant function analysis was
used to determine the set of patients’ clinical characteristics
that produce the best discrimination between ACS patients
with performed PCI and without it. We used the following
stepwise options to remove cases: the tolerance value was
0.01, the remove value of F was 10.0, and the number of steps
was not limited.
Obtained estimations were considered statistically signiﬁ-
cant if Po0.05. Software package Statistica 6.1 (Statsoft Inc.,
USA) was used for statistical analysis.Results
ACCF 2012 criteria in ACS-PCI patients
Among ACS-PCI patients (n¼9147), coronary revascularisa-
tion was performed appropriately in 6303 patients (68.9%).
PCI was inappropriate in 418 ACS-PCI patients (4.6% of all
ACS-PCI patients). The appropriateness of performed PCI was
uncertain in 523 patients (5.7% of all ACS-PCI patients) (Fig. 1).
Frequency of ACCF 2012 criteria in all ACS-PCI patients is
shown in Fig. 2.
The most of ACS patients, who have undergone appropriate
PCI, fulﬁlled criteria nos. 1, 10, 11 and 13 (58.6%, 21.2%, 16.2%
and 5.4% of patients with appropriate PCI, respectively). Among
ACS-PCI patients in whom the appropriateness of PCI was
uncertain, criteria no. 9 was applicable in 85.3% of patients.
The appropriateness of PCI was not evaluated in 1903
ACS-PCI patients (20.8% of all ACS-PCI patients), because of
absence of suitable criteria in ACCF 2012 [9].ACCF 2012 criteria in ACS-nonPCI patients
Among ACS-nonPCI patients (n¼56,765), coronary revascu-
larisation would be appropriate in 32,909 patients (57.9% of all
ACS-nonPCI patients) (Fig. 1). PCI was not needed for 2404
ACS-nonPCI patients (4.2%). The potential appropriateness of
the procedure was uncertain in 10,511 patients (18.5%).
Frequency of ACCF 2012 criteria in all ACS-nonPCI patients
is shown in Fig. 2.
The most of ACS-nonPCI patients, in whom PCI would be
appropriate, fulﬁlled criteria nos. 1, 10, 11 and 13 (20.7%,
18.6%, 55.2% and 7.5% of patients with appropriate PCI,
respectively). 99.8% of ACS-nonPCI patients with uncertain
appropriateness of PCI met the criterion no. 9.
PCI appropriateness was not evaluated in 10,941 ACS-
nonPCI patients (19.4% of all ACS-nonPCI patients), because
of absence of suitable criteria in ACCF 2012 [9].
Association between patients' clinical characteristics and PCI
performance
We studied associations between patients' clinical character-
istics and PCI implementation separately in ACS-PCI patients
and in ACS-nonPCI patients. Each group of patients was
subdivided according to PCI appropriateness (appropriate,
Table 2 – ACCF 2012 coronary revascularization appropriate use criteria for ACS patients [9], exploited in this study.
Criteria Appropriate use
score (1–9)
No. Deﬁnition
1  STEMI
 Less than or equal to 12 hours from onset of symptoms
 Revascularization of the culprit artery A (9)
2  STEMI
 Onset of symptoms within the prior 12 to 24 hours
 Severe HF, persistent ischemic symptoms, or hemodynamic or electrical instability present A (9)
3  STEMI
 Greater than 12 hours from symptom onset
 Asymptomatic; no hemodynamic instability and no electrical instability I (3)
4  STEMI with presumed successful treatment with ﬁbrinolysis
 Evidence of HF, recurrent ischemia, or unstable ventricular arrhythmias present
 One-vessel CAD presumed to be the culprit artery A (9)
5  STEMI with presumed successful treatment with ﬁbrinolysis
 Asymptomatic; no HF or no recurrent ischemic symptoms, or no unstable ventricular arrhythmias
 Normal LVEF
 One-vessel CAD presumed to be the culprit artery U (5)
6  STEMI with presumed successful treatment with ﬁbrinolysis
 Asymptomatic; no HF, no recurrent ischemic symptoms, or no unstable
ventricular arrhythmias at the time of presentation
 Depressed LVEF
 Three-vessel CAD
 Elective/semielective revascularization A (8)
9  UA/NSTEMI and low-risk features (e.g., TIMI score 2) for short-term risk of death or nonfatal MI
 Revascularization of the presumed culprit artery
U (6)
10  UA/NSTEMI and intermediate-risk features (e.g., TIMI score 3–4) for short-term risk of death or nonfatal MI
 Revascularization of the presumed culprit artery
A (8)
11  UA/NSTEMI and high-risk features for short-term risk of death or nonfatal MI
 Revascularization of the presumed culprit artery
A (9)
12  UA/NSTEMI and high-risk features for short-term risk of death or nonfatal MI
 Revascularization of multiple coronary arteries when the culprit artery cannot
clearly be determined A (9)
13  Patients with acute myocardial infarction (STEMI or NSTEMI)
 Evidence of cardiogenic shock
 Revascularization of 1 coronary arteries A (9)
A, appropriate; HF, heart failure; I, inappropriate; NSTEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation
myocardial infarction; TIMI, Thrombolysis In Myocardial Infarction; U, uncertain; UA, unstable angina.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0 e5inappropriate, uncertain). Backward stepwise discriminant
function analysis was applied for this goal. We constructed
discriminant model based on clinical data, including ACCF
2012 criteria, for two groups of ACS patients, differed from
each other by PCI performance or refuse. Constructed dis-
criminant model included 28 variables and had Wilks'
Lambda¼0.78 and F(28.25)¼248.45, Po0.001. The percent of
correctly classiﬁed cases using the constructed model was
94.9% for ACS-PCI patients and 37.5% for ACS-nonPCI
patients. Summary statistics for all variables of the model is
presented in Table 3. Constructed model have shown a low
discriminant power (Wilks' Lambda levels more than 0.5 for
each variable and for the overall model). The model poorly
determined ACS-nonPCI patients. But ACS-PCI patients wereperfectly determined using the constructed discriminant
model.
The pooled within-groups correlations of variables accord-
ing to their discriminant functions are shown in Table 4.
These correlations may be considered as the factor loadings
of the respective variables on the discriminant functions.
Therefore, the main clinical factors associated with PCI
implementation were ACCF 2012 criterion no. 1 (STEMI and
12 h or less from symptom onset), ST-segment elevation on
ECG, and male sex. In ACS-nonPCI patients, ACCF 2012
appropriate use criterion no. 11 (UA/NSTEMI and high risk
features for short-term risk of death or non-fatal MI), the
increase in the age, and CHF were signiﬁcantly associated
with the refuse from PCI.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0e6Discussion
Up-to-date international research showed restricted data on
treatment of Russian ACS patients, especially concerning
their invasive treatment. The most known international
project involving centers from Russia is Euro Heart Survey
(EHS) [22]. But Russian ACS patients were not analyzed
separately from patients of the other countries. Thereafter,
the design of EHS was reproduced in Russian project RECORD
(2007/08) and RECORD-2 (2009/11). There were web-based
voluntary registries [23]. The most published data were based
on RECORD registry, which included 796 patients from 18
centers in 14 regions of Russian Federation [24].
The present study elucidated some aspects of PCI imple-
mentation in everyday practice of Russian hospitals partici-
pating in Russian ACS Registry. The appropriateness of PCIFig. 1 – Frequencies of appropriate, inappropriate and
uncertain PCI, according to ACCF 2012 criteria in ACS-PCI
patients (n¼9147) and ACS-nonPCI patients (n¼56,765).
Fig. 2 – Frequencies of ACCF 2012 criteria in ACS-PCI patients a
percents of all patients in appropriate group. nSigniﬁcant differewith the help of evidence-based criteria was evaluated. We
also tried to investigate how patient's clinical characteristics
inﬂuence on a doctor's decision to perform PCI.
According to the data from hospitals, participated in the
2010/11 Russian ACS Registry, 13.8% of all ACS patients
underwent invasive coronary revascularization. The data
derived from 2008/10 Russian ACS Registry showed that
12.8% of all ACS patients underwent PCI. Among them
22.3% of patients had ST-segment-elevation ACS and 7.6%
of patients had non-ST-segment-elevation ACS [14].
The data were derived from selected population of the site
based registry and may not reﬂect the overall population of
Russian ACS patients. The previous study of ACS practice
conducted in Russia called RECORD Registry showed similar
results: PCI was performed in 18.7% of patients with ST-
segment-elevation ACS and in 11.4% of patients with non-ST-
segment-elevation ACS [24]. There were no other signiﬁcant
national surveys dedicated to treatment of ACS in Russia.
In European countries, PCI traditionally is more frequently
performed. According to the data of Euro Heart Survey Acute
Coronary Syndrome snapshot 2009, PCI was performed in
54% of ACS patients treated in European Society of Cardiology
countries [25] including 57.8% of patients with ST-elevation
ACS 37.1% of patients with non ST-elevation ACS. In TARGET
study conducted in Greece, 27% of ACS patients underwent
PCI [26].
But the part of ACS patients, who have undergone invasive
treatment, varied largely across EU countries and even across
separate hospitals within a country. It was reported in Euro
Heart Survey [27] and conﬁrmed by P. Widimsky and co-
authors in the study of reperfusion therapy for ST elevation
acute myocardial infarction in 30 European countries [28].
In the last named survey the data were derived from national
registries. The frequency of primary PCI varied from 5% in
Romania to 92% in Czech Republic. This heterogeneity of
results of different registries should be taken into account
considering the results of the present study.
Analysis of PCI appropriateness using ACCF 2012 criteria
showed the following results. It was possible to evaluate the
appropriateness of PCI with the help of ACCF 2012 criteria innd ACS-nonPCI patients. Frequencies are presented as
nce (Po0.05) from the same criterion in ACS-PCI patients.
Table 3 – Summary statistics for all variables in the discriminant model for classiﬁcation of ACS patients into two groups
(ACS-PCI patients and ACS-nonPCI patients) based on clinical data.
No. Variables Wilks' Lambda Partial Lambda F-remove P-level Tolerance
1 Criterionn no. 1 0.82 0.95 1258.84 o0.001 0.55
2 Age 0.79 0.98 368.52 o0.001 0.77
3 Criterionn no. 9 0.79 0.99 240.64 o0.001 0.08
4 Criterionn no. 12 0.79 0.99 193.45 o0.001 0.99
5 Criterionn no. 5 0.79 0.99 164.05 o0.001 0.98
6 Criterionn no. 4 0.79 0.99 156.45 o0.001 0.98
7 Criterionn no. 11 0.79 0.99 140.69 o0.001 0.05
8 Male sex 0.79 0.99 95.21 o0.001 0.84
9 Prior PCI 0.79 0.99 93.44 o0.001 0.90
10 ST-segment elevation on ECG 0.79 0.99 70.19 o0.001 0.04
11 AHF Killip 2–4 0.79 0.99 61.79 o0.001 0.86
12 HR 0.79 0.99 58.45 o0.001 0.96
13 Criterionn no. 10 0.78 0.99 46.44 o0.001 0.09
14 In-hospital bleeding 0.78 0.99 45.56 o0.001 0.99
15 SBP 0.78 0.99 41.29 o0.001 0.91
16 AH 0.78 0.99 41.11 o0.001 0.83
17 Serum creatinine 0.78 0.99 40.85 o0.001 0.98
18 Statins (Pr.tr.) 0.78 0.99 39.74 o0.001 0.74
19 CHF 0.78 0.99 35.47 o0.001 0.74
20 Fibrinolytic therapy 0.78 0.99 28.88 o0.001 0.57
21 ACE-Is or ARBs (Pr.tr.) 0.78 0.99 23.72 o0.001 0.76
22 Prior stroke 0.78 0.99 22.85 o0.001 0.97
23 COLD 0.78 0.99 22.39 o0.001 0.98
24 LT arrhythmias 0.78 0.99 18.79 o0.001 0.96
25 Prior MI 0.78 0.99 16.00 o0.001 0.74
26 Nitrates (Pr.tr.) 0.78 0.99 15.38 o0.001 0.69
27 Aspirin (Pr.tr.) 0.78 0.99 13.09 o0.001 0.55
28 Degree of MR 0.78 0.99 12.42 o0.001 0.96
Criterionn is ACCF 2012 criterion. Pr.tr., prior treatment; LT arrhythmias, life threatening arrhythmias; MR, mitral regurgitation.
Wilks' Lambda is the Wilks' Lambda for the overall model that will be obtained after removing the respective variable. Wilks' Lambda can take
values in the range of 0 (perfect discrimination) to 1 (no discrimination).
Partial Lambda is the Wilks' Lambda associated with the unique contribution of the respective variable to the discriminatory power of
the model.
F-remove is the F-value associated with the respective partial Wilk's Lambda. P-level is associated with the respective F-remove.
Tolerance is a measure of the respective variable's redundancy, computed as 1R-square of the respective variable with all other variables in
the model.
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patients refused from PCI. In all, 80.5% of ACS patients
included in the study ﬁt to at least one of ACCF 2012 criteria.
The other 19.5% of patients enrolled in the study did not meet
any of ACCF 2012 criteria.
The present study revealed that performed PCI was appro-
priate in 68.9% of ACS-PCI patients (Fig. 1). In 4.6% of ACS-PCI
patients, the conducted revascularization was inappropriate.
Inappropriate use of PCI is higher in Russia than in other
countries. According to data of NDCR, Paul S. Chan et al.,
PCI was appropriate in 98.6%, inappropriate in 1.1% and
uncertain in 0.3% of ACS-PCI patients [29]. Similar results
were obtained by Steven M. Bradley et al. The authors showed
that PCI was appropriate in 82%, inappropriate in 1% and
uncertain in o1% of ACS-PCI patients in Washington State
(USA) [30]. According to [29], 98.6% of acute PCIs were
classiﬁed as appropriate in large US cohort of ACS patients.
It was found that 60.5% of ACS-non-PCI patients required
PCI according to ACCF 2012 criteria (Fig. 2). The appropriate-
ness of PCI was uncertain in 5.7% of patients from ACS-PCI
group and in 18.5% of patients from ACS-nonPCI group. It wasshown that if beneﬁt of PCI was questionable (ACCF 2012
criterion no. 9; Fig. 2), the patients were refused from PCI
three times more often than underwent it. However, according
to [31] such ACS patients had similar favorable outcomes as
those with appropriate PCI, both during initial hospitalization
and during the subsequent 3 years.
Our results demonstrated that PCI was most commonly
performed in patients with ST-segment elevation myocardial
infarction (STEMI) on culprit artery during 12 h from symptom
onset (ACCF 2012 criterion no. 1; Fig. 2). Inappropriate PCI was
often performed in STEMI patients without hemodynamic and
electrical instability longer than 12 h from symptom onset
(ACCF 2012 criterion no. 3; Fig. 2). PCI was not performed in
patients with unstable angina or non-ST-segment elevation
myocardial infarction (NSTEMI) and high-risk of short-term
mortality or nonfatal myocardial infarction (MI) (ACCF 2012
criterion no. 11; Fig. 2). It means the overuse of PCI in
ST-elevation ACS and its underuse in non ST-elevation ACS.
In the present study, the most of clinical characteristics
and short-term outcomes of non-revascularised patients
differed from those in revascularised ACS patients and were
Table 4 – Discriminant model factor structure matrix for
classiﬁcation of ACS patients into two groups (ACS-PCI
patients and ACS-nonPCI patients) based on clinical data.
No. Variables Pooled-within-groups
correlations
1 Criterionn no. 11 0.39
2 Age 0.35
3 CHF 0.26
4 Criterionn no. 9 0.25
5 Nitrates (Pr.tr.) 0.20
6 ACE-Is or ARBs (Pr.tr.) 0.18
7 SBP 0.15
8 Aspirin (Pr.tr.) 0.14
9 AHF Killip 1–4 0.13
10 Degree of MR 0.13
11 Serum creatinine 0.13
12 HR 0.12
13 Prior MI 0.10
14 COLD 0.09
15 AH 0.08
16 Prior stroke 0.07
17 Fibrinolytic therapy 0.01
18 Statins (Pr.tr.) 0.03
19 Criterionn no. 10 0.06
20 Bleeding in hospital 0.09
21 LT arrhythmias 0.12
22 Criterionn no. 4 0.14
23 Prior PCI 0.14
24 Criterionn no. 12 0.14
25 Criterionn no. 5 0.15
26 Male sex 0.29
27 ST-segment elevation
on ECG
0.49
28 Criterionn no. 1 0.69
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 – e 1 0e8similar to those obtained in other studies. As well as in [32],
it was shown that non-revascularized patients were signiﬁ-
cantly older than revascularized patients, the majority of
them were women having high-blood pressure, type-2 dia-
betes, history of atherothrombotic or cardiac disease, and the
remaining part had a history of coronary angioplasty
(Table 1). But in contrast to the results of [32], our study
showed that ACS-PCI and ACS non-PCI patients had no
differences in body mass index (BMI) and pathological
Q-wave on ECG. Elbarasi et al. [33] showed that NSTEMI patients
with previous PCI were treated invasively more frequently.
Conversely, the patients with prior CABG received invasive
therapy less frequently. Our results conﬁrmed this fact.
We have studied clinical factors associated with PCI
performance among Russian ACS patients. The following
main ten factors determining PCI performance were revealed:
age, male sex, prior PCI, ST-segment elevation on electro-
cardiogram (ECG), ACCF 2012 criteria nos. 1, 4, 5, 9, 11 and 12
(Table 3).
The constructed discriminant model best of all described
ACS-PCI patients (94.9%). Only about a third (37.5%) of ACS-
non-PCI patients was described by this model. It means that
clinical factors were crucial when decision to perform PCI was
made, but refuse from PCI was determined by other, non-
clinical factors such as hospitals’ PCI capability, staff etc. The
study of impact of non-clinical factors on PCI implementationwas out of scope of the present paper. It will be the issue for
our future research.
PCI implementation in ACS patients is a problem for
Russian healthcare. Improvement and extension of technical
equipment of catheterization laboratories observed during
the last decade is still insufﬁcient and PCI availability for ACS
patients is low. Absence of association between the refuse
from PCI and clinical characteristics of ACS patients empha-
sizes the role of further study on organizational, economic,
human and other reasons resulting in doctors’ decision not to
perform PCI.
Study limitations
The results of the study were derived from the data on ACS
patients, included in the Russian ACS Registry with voluntary
participation. Since participation in the Russian ACS Registry
was voluntary, the centers which participated could be highly
equipped and highly motivated, willing to expose their
practice to criticism and more likely to adhere to guidelines.
Thus, extrapolation of the results to ACS patients of the
whole country, as well as from other countries is limited.
We did not include people older than 80 years in this
study. The reasons to exclude them are indicated in the
Methods section. Exclusion of all patients over 80 years limits
the extrapolation of the results.
ACS-PCI patients comprised 13.8% of the overall amount of
the analyzed group. Age-sex distribution and several clinical
characteristics were differed between ACS-PCI and ACS-non-
PCI group. We tried to overcome the difference in volumes of
compared groups (ACS-PCI vs. ACS-non-PCI) with the help of
statistical methods, but clinical implication of obtained
results may be attenuated.
Non-clinical factors (administrative, economic, social, etc.)
inﬂuencing on PCI implementation, were not studied because
of absence of necessary information in the Russian ACS
Registry database. This aspect needs further research.
In the present paper we have not studied 19.5% of ACS
patients who did not meet one of ACCF 2012 criteria. It will be
the next step of our future study.Conclusion
Our study showed that for the majority of ACS patients,
who have undergone PCI, the procedure was appropriate.
Among patients, refused from revascularization, PCI would
be appropriate in more than half of them. We revealed that
several clinical characteristics of ACS patients, including
ACCF 2012 criteria, bring in the main impact on positive
decision to perform PCI, but the negative decision was
determined by other, non-clinical factors.Conﬂict of interest
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